Andreas Pospischil 1

Similar documents
Cancer in Estonia 2014

APPENDIX ONE: ICD CODES

CODING PRIMARY SITE. Nadya Dimitrova

CODING TUMOUR MORPHOLOGY. Otto Visser

CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996

Cancer survival in Hong Kong SAR, China,

Cancer in Central and South America BOLIVIA

CHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster

Epidemiology in Texas 2006 Annual Report. Cancer

THE INCIDENCE OF EPITHELIAL NEOPLASMS IN PETS (DOG AND CATS)

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

Overview of 2010 Hong Kong Cancer Statistics

Hazelinks - Cancer incidence analysis (First data extraction)

Cancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer

ANNUAL CANCER REGISTRY REPORT-2005

Icd 10 code lung ca with mets to bone

Prediction of Cancer Incidence and Mortality in Korea, 2018

Cancer survival in Shanghai, China,

Research Article Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program

Supplementary Online Content

Prediction of Cancer Incidence and Mortality in Korea, 2013

Cancer survival in Busan, Republic of Korea,

Cancer in the Northern Territory :

AJCC 7th Edition Handbook Errata as of 9/21/10

Cancer in New Mexico 2017

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site

Case # nd Annual SEVPAC May 17, Kathy-Anne Clarke

Cancer Association of South Africa (CANSA)

From A to Z-Codes Matter

American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013

The European Commission s science and knowledge service. Joint Research Centre

ALL CANCER (EXCLUDING NMSC)

Cancer in New Mexico 2014

Cancer in Norway Cancer incidence, mortality, survival and prevalence in Norway

Overview of Anatomy & Physiology

Nov FromAtoZCodesMatter

Overview of 2013 Hong Kong Cancer Statistics

Cancer in Norway Cancer incidence, mortality, survival and prevalence in Norway

A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files

Common Canine Cancers Why do we care & what to look for at home

HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011

ALL CANCER (EXCLUDING NMSC)

SMOKING AND CANCER RISK

Checklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005

Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER

Sex Distribution of Solid Malignant Tumours in Basrah Retrospective Study

Cancer in Norway Cancer incidence, mortality, survival and prevalence in Norway

Overview of 2009 Hong Kong Cancer Statistics

GSK Medicine: Study No.: Title: Rationale: Objectives: Indication: Study Investigators/Centers: Research Methods:

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Introduction to ICD-O-3 coding rules

Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute

Cancer incidence in the Republic of Mauritius- 5 Years Review 1997 to 2001

NUCLEAR MORPHOMETRY IN RELATION TO METASTASES IN CANINE SPONTANEOUS CUTANEOUS SQUAMOUS CELL CARCINOMAS

Cancer prevalence. Chapter 7

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary

AUSTRALIAN AND NEW ZEALAND COLLEGE OF VETERINARY SCIENTISTS FELLOWSHIP GUIDELINES. Veterinary Oncology

Format Of ICD-O Terms In Numerical List Each topographic and morphologic term appears only once The first listed term in Bold Type is the Preferred Te

*

Cancer in New Brunswick

Canine Cutaneous Melanoma

Icd 10 code for esophageal cancer stage 4

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.

Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths

CANCER IN TASMANIA INCIDENCE AND MORTALITY 1995

3 Materials and Methods

I.2 CNExT This section was software specific and deleted in 2008.

Estimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004

Lymphoma in Cats. THE PET HEALTH LIBRARY By Wendy C. Brooks, DVM, DipABVP Educational Director, VeterinaryPartner.com

2. Occupancy rate of beds in the hospital: Occupancy rate of at least 60%

Identifying and counting people living with treatable but not curable cancer

Suicides increased in 2014

Pathology of the Liver and Biliary Tract 5 Diseases of the Biliary Tract. Shannon Martinson, March 2017

7/4/2018. Key Objectives. A and P 2401 Lecture 2 TWO MECHANISMS USED TO MAINTAIN HOMEOSTASIS. Negative Feedback Examples. Review of Homeostasis

Neoplasia part I. Dr. Mohsen Dashti. Clinical Medicine & Pathology nd Lecture

Cancer A Superficial Introduction

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013

CLIC Sargent Eligibility Criteria

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

Cancer survival in Seoul, Republic of Korea,

THE PATTERN OF MALIGNANT TUMOURS IN NORTHERN PAKISTAN

Overview of Hong Kong Cancer Statistics of 2015

DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #

Key Words. Cancer statistics Incidence Lifetime risk Multiple primaries Survival SEER

Schweizer Register für Neuroendokrine Tumore Le Registre Suisse des tumeurs neuroendocrines Registro Svizzero per i Tumori Neuroendocrini

SKCC Protocol Review Committee New Study Application

came from a carcinoma and in 12 from a sarcoma. Ninety lesions were intrapulmonary and the as the chest wall and pleura. Details of the primary

UK CAA Oncology Certification Charts

FAMILIAL CARCINOID TUMORS AND SUBSEQUENT CANCERS: A NATION-WIDE EPIDEMIOLOGIC STUDY FROM SWEDEN

Histiocytic Neoplasms of the Dog and Cat

Cancer Statistics in Korea: Incidence, Mortality and Survival in

Supplementary Online Content

SMOKING AND CANCER RISK

Information Services Division NHS National Services Scotland

Icd 10 code pancreatic cancer

Supplementary Online Content

Cancer in Ireland : Annual Report of the National Cancer Registry

Information Services Division NHS National Services Scotland

Transcription:

Andreas Pospischil 1

v v v Introduction Swiss canine cancer registry Comparing data from dogs & humans in 2

Companion animal epidemiological study lacks companion animal data since current and prior veterinary registries are few in number and scattered [Broenden et al. 2007] 3

Why pet models for human cancer? Pets, i.e. dogs & cats closely share human environment Genetic/phenotypic analogy of many human and canine / feline tumour types First world countries: veterinary medical care of dogs and cats largely comparable to human medical care (diagnostic procedures, surgery,, drug 4

Some published animal cancer Institution Start Duration Entries registries Kansas University Neoplasm Registry Records California Animal Neoplasm Registry Tulsa Registry of Canine and Feline Neoplasms Purdue Comparative Oncology Program Cancer Registry and Surveillance System Compan. Animals 1961 11 yrs 1963 3 yrs 1972 5 yrs 1979 - Species Dogs, 4.124 horses Dogs, 30 cats Dogs, cats 20 1980 ongoing 170 Norwegian cancer project 1990 ongoing 14.401 VetCancer Registry 1994 ongoing - Danish Veterinary Cancer Registry 2005 ongoing 1 Animal Tumour Registry Genova 1985 Animal Tumour Registry north. Italy 2005 7 years 3 yrs, tel. survey 6.743 2.509 (dog); 494 (cat) 5 Dogs Dogs, cats Dogs, cats Dogs, cats Dogs Dogs, cats

6

Cancer data sources for canine and feline patients in Switzerland Canine population & breed distribution in 7

Canine / feline cancer patient data sources Source Time period IVPZ 1955-1964 IVPZ IVPZ IVPZ IVPZ private lab. ITP Berne 1964-1988 1989-2008 1989-2008 1992-2008 2007-2009 1995-1999 Examination type p. m. (hand written) p. m. / biopsy Dog Cat X (punch cards) X X p. m. biopsy cytology X X X X X X X X X X biopsy biopsy 8

KEYDEX punch card 3`000 cards converted into a digital database 40 x 40 cm 9

Data Swiss canine & feline cancer registry: patients Species (time period) Dogs (1955 2008) Cats (1965 2008) Patients total (n) Cancer patients (n / %) 121.96 63.214 51% 4 17.856 51.322 39% 10

WHO: International Classification of Diseases for Oncology, 3rd Edition Used principally in human cancer (ICD-O-3), 2000 registries for coding the site (topography) and the histology (morphology) of neoplasms, usually obtained from a pathology report. 11

Data on canine population and breeds in Switzerland (1953-2008) Continuous increase of canine population from n = 308.979 (1955) to n = 506.616 (2008) 12

Number of dogs per 100 inhabitants in Switzerland 13

Summary / introduction Case numbers for dogs sufficient for an incidence study Case numbers for dogs and the availability of population data (CH: since 2006) sufficient for an in depth epidemiologic study 14

v v v Introduction Swiss canine cancer registry Comparing data from dogs humans in 15

Swiss Canine Cancer Registry: DVM thesis: Katrin Grüntzig Geographic distribution in Switzerland: PhD thesis in geography: Gianluca Boo 16

17

From: Withrow and MacEwen's: Small Animal Clinical Oncology, 2012 18

Age dependant tumor incidence (OR) of dogs compared to patients under one year of age (OR 1) 19

Cancer in canine breeds (OR) 20

Mammary gland Mammary gland Skin Soft tissue GI tract Oral cavity, pharynx Endocrine glands Male sex organs Bone, joints Mammary gland Spleen, bone marrow Resp. organs, heart 21

Probability (OR) for purebreds to develop a tumor compared to crossbreeds and risk to develop a malignant tumor vs. no tumor pure breeds compared to crossbreeds Tumor Malignant tumor Number of obs 90,085 Clinically moderately relevant 22

Breed risk to develop a malignant tumor (Odds ratio, OR) Clinically moderately relevant 23

Risk (OR) to develop a mammary gland tumour pure-breed vs. mixed breed dogs (OR1). Clinically strongly relevant 24

Risk (OR) to develop a skin tumor pure-breed vs. mixed breed dogs (OR1) Clinically weakly relevant Clinically strongly relevant 25

v v v Introduction Swiss canine cancer registry Comparing data from dogs & humans in 26

Comparing cancer data from dogs & humans 27

28

Comparing canine to human tumor locations; significantly more canine tumors in: Oral cavity & pharynx Anus & analcanal bone, cartilage, joints Connective tissue Mamma Testis 29

Comparing canine to human tumor locations; significantly less canine tumors in: Stomach Intestine Liver, gallbladder Pancreas Lung Melanoma Ovary Prostata Kidney 30

v v v Introduction Swiss canine cancer registry Comparing data from dogs & humans in 31

Swiss Canine Cancer Registry: DVM thesis: Katrin Grüntzig Geographic distribution in Switzerland: PhD thesis in geography: Gianluca Boo 32

Canine cancer patients per Swiss Kanton 33

Canine patients / Swiss Kanton 34

Canine tumor incidence in Switzerland 35

Canine cancer incidences in Switzerland Cancer incidences (Quantiles) 6-7 3-5 2 1 0 No data Identify structural zeros and filter them out from models of canine cancer incidence. Assess changes in the statistical associations associated with the filtering step. Boo G, Leyk S, Fabrikant SI, Graf R and Pospischil A. 2016. Assessing effects of structural zeros on models of canine cancer incidence: a case study of the Swiss Canine Cancer Registry. [Submitted to Geospatial Health]. 36

Human cancer incidence in Switzerland Male 2006-2010 Female 2006-2010 Age Standardized Rates per 100.000 Person Years Quelle: NICER 37

Studies using companion animals to investigate environmental causes of cancer (Bukowski and Wartenberg 1997) Study Buck 1979 Ragland 1967 Reif and Cohen 1970 Reif and Cohen 1971 Hayes et al. 1981 Harbison and Godleski 1983 Glickman et al. 1983 Glickman et al. 1989 Hayes et al. 1990 Reif et al. 1992 Reif et al. 1995 Type Prevalence comparison Prevalence comparison Crude Case-control Mortality correlation Crude case-control Case-control Disease Tonsilar carcinoma Case-control Prevalence comparaison Case-control Case-control Case-control Bladder cancer Seminoma Pulmonary changes Tonsillary carcinoma Bladder cancer Mesothelioma Mesothelioma Lymphoma Lung cancer Lymphoma 38

Acknowledgement Katrin Grüntzig, Ramona Graf, Michael Hässig, Franco 39